337 related articles for article (PubMed ID: 16773191)
1. Aberrant expression of histone deacetylase 6 in oral squamous cell carcinoma.
Sakuma T; Uzawa K; Onda T; Shiiba M; Yokoe H; Shibahara T; Tanzawa H
Int J Oncol; 2006 Jul; 29(1):117-24. PubMed ID: 16773191
[TBL] [Abstract][Full Text] [Related]
2. Hyaluronan-mediated motility: a target in oral squamous cell carcinoma.
Yamano Y; Uzawa K; Shinozuka K; Fushimi K; Ishigami T; Nomura H; Ogawara K; Shiiba M; Yokoe H; Tanzawa H
Int J Oncol; 2008 May; 32(5):1001-9. PubMed ID: 18425326
[TBL] [Abstract][Full Text] [Related]
3. HDAC6 expression is correlated with better survival in breast cancer.
Zhang Z; Yamashita H; Toyama T; Sugiura H; Omoto Y; Ando Y; Mita K; Hamaguchi M; Hayashi S; Iwase H
Clin Cancer Res; 2004 Oct; 10(20):6962-8. PubMed ID: 15501975
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of 1D-myo-inositol 1,4,5-trisphosphate 3-kinase A protein expression in oral squamous cell carcinoma.
Kato H; Uzawa K; Onda T; Kato Y; Saito K; Nakashima D; Ogawara K; Bukawa H; Yokoe H; Tanzawa H
Int J Oncol; 2006 Apr; 28(4):873-81. PubMed ID: 16525636
[TBL] [Abstract][Full Text] [Related]
5. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.
Su L; Wang Y; Xiao M; Lin Y; Yu L
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995
[TBL] [Abstract][Full Text] [Related]
6. State of homeobox A10 expression as a putative prognostic marker for oral squamous cell carcinoma.
Yamatoji M; Kasamatsu A; Yamano Y; Sakuma K; Ogoshi K; Iyoda M; Shinozuka K; Ogawara K; Takiguchi Y; Shiiba M; Tanzawa H; Uzawa K
Oncol Rep; 2010 Jan; 23(1):61-7. PubMed ID: 19956865
[TBL] [Abstract][Full Text] [Related]
7. Decreased expression of Annexin A1 correlates with pathologic differentiation grade in oral squamous cell carcinoma.
Zhang L; Yang X; Zhong LP; Zhou XJ; Pan HY; Wei KJ; Li J; Chen WT; Zhang ZY
J Oral Pathol Med; 2009 Apr; 38(4):362-70. PubMed ID: 18673418
[TBL] [Abstract][Full Text] [Related]
8. Expression of multi-drug resistance genes (mdr1, mrp1, bcrp) in primary oral squamous cell carcinoma.
Friedrich RE; Punke C; Reymann A
In Vivo; 2004; 18(2):133-47. PubMed ID: 15113040
[TBL] [Abstract][Full Text] [Related]
9. miR-433 inhibits oral squamous cell carcinoma (OSCC) cell growth and metastasis by targeting HDAC6.
Wang XC; Ma Y; Meng PS; Han JL; Yu HY; Bi LJ
Oral Oncol; 2015 Jul; 51(7):674-82. PubMed ID: 25962939
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of Eps8 in oral squamous cell carcinoma promotes cell migration and invasion through integrin-dependent Rac1 activation.
Yap LF; Jenei V; Robinson CM; Moutasim K; Benn TM; Threadgold SP; Lopes V; Wei W; Thomas GJ; Paterson IC
Oncogene; 2009 Jul; 28(27):2524-34. PubMed ID: 19448673
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of insulin-like growth factor binding protein 3 in oral squamous cell carcinoma.
Zhong LP; Yang X; Zhang L; Wei KJ; Pan HY; Zhou XJ; Li J; Chen WT; Zhang ZY
Oncol Rep; 2008 Dec; 20(6):1441-7. PubMed ID: 19020726
[TBL] [Abstract][Full Text] [Related]
12. RNAi-mediated down-regulation of alpha-actinin-4 decreases invasion potential in oral squamous cell carcinoma.
Yamada S; Yanamoto S; Yoshida H; Yoshitomi I; Kawasaki G; Mizuno A; Nemoto TK
Int J Oral Maxillofac Surg; 2010 Jan; 39(1):61-7. PubMed ID: 19913389
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of carcinoembryonic antigen-related cell adhesion molecule 1 in oral squamous cell carcinoma: correlation with tumor progression and poor prognosis.
Shinozuka K; Uzawa K; Fushimi K; Yamano Y; Shiiba M; Bukawa H; Yokoe H; Tanzawa H
Oncology; 2009; 76(6):387-97. PubMed ID: 19407471
[TBL] [Abstract][Full Text] [Related]
14. [Expression of osteopontin mRNA in oral squamous cell carcinoma and normal oral mucosa].
Lu XZ; Yin XM; Feng YY; Duan LQ; Chen WT; Zhang CP
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jul; 28(7):1165-7. PubMed ID: 18676253
[TBL] [Abstract][Full Text] [Related]
15. Status of reduced expression and hypermethylation of the APC tumor suppressor gene in human oral squamous cell carcinoma.
Uesugi H; Uzawa K; Kawasaki K; Shimada K; Moriya T; Tada A; Shiiba M; Tanzawa H
Int J Mol Med; 2005 Apr; 15(4):597-602. PubMed ID: 15754020
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of galectin-1 at the tumor invasion front is associated with poor prognosis in early-stage oral squamous cell carcinoma.
Chiang WF; Liu SY; Fang LY; Lin CN; Wu MH; Chen YC; Chen YL; Jin YT
Oral Oncol; 2008 Apr; 44(4):325-34. PubMed ID: 17588803
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of Cathepsin B in oral squamous cell carcinoma.
Yang X; Wei KJ; Zhang L; Pan HY; Li J; Chen WT; Zhong LP; Zhang ZY
Int J Oral Maxillofac Surg; 2010 Feb; 39(2):174-81. PubMed ID: 20042316
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of Annexin A2 in oral squamous cell carcinoma.
Zhong LP; Wei KJ; Yang X; Zhang L; Zhou XJ; Pan HY; Li J; Chen WT; Zhang ZY
Arch Oral Biol; 2009 Jan; 54(1):17-25. PubMed ID: 18822406
[TBL] [Abstract][Full Text] [Related]
19. Acetylation of histone deacetylase 6 by p300 attenuates its deacetylase activity.
Han Y; Jeong HM; Jin YH; Kim YJ; Jeong HG; Yeo CY; Lee KY
Biochem Biophys Res Commun; 2009 May; 383(1):88-92. PubMed ID: 19344692
[TBL] [Abstract][Full Text] [Related]
20. Galectin-9 as a regulator of cellular adhesion in human oral squamous cell carcinoma cell lines.
Kasamatsu A; Uzawa K; Nakashima D; Koike H; Shiiba M; Bukawa H; Yokoe H; Tanzawa H
Int J Mol Med; 2005 Aug; 16(2):269-73. PubMed ID: 16012760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
